Transcatheter aortic valve replacement (TAVR) is a treatment option for symptomatic
patients with severe aortic stenosis who are candidates for a bioprosthesis across the entire …

Transcatheter aortic valve replacement (TAVR) is approved for all patient risk profiles and is
an option for all patients irrespective of age. However, patients enrolled in the low-and …

Significant coronary artery disease (CAD) is a frequent finding in patients with severe aortic
stenosis undergoing transcatheter aortic valve implantation (TAVI), and the management of …

Objectives The aims of this study were to investigate the feasibility of coronary ostia
cannulation after transcatheter aortic valve replacement (TAVR) and to assess potential …

Background Among patients with acute coronary syndrome following transcatheter aortic
valve replacement (TAVR), those presenting with ST-segment elevation myocardial …

Right ventricular myocardial infarction (RVMI) and right ventricular (RV) failure are
complications from an acute occlusion of a dominant right coronary artery (RCA) or left …

Objectives This study sought to determine, in patients undergoing percutaneous coronary
intervention (PCI) during the work-up pre–transcatheter aortic valve replacement (TAVR): 1) …

Objectives The aim of this study was to characterize the feasibility of coronary angiography
(CA) and percutaneous coronary intervention (PCI) in acute settings among patients who …

Background Coronary re-engagement after transcatheter aortic valve replacement (TAVR)
using self-expanding transcatheter heart valves (THVs) systematically implanted using …

Background Coronary access after transcatheter aortic valve replacement (TAVR) can be
challenging and complicate percutaneous coronary intervention (PCI). Aims We aimed to …